ClinicalTrials.Veeva

Menu

Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine

Sun Yat-sen University logo

Sun Yat-sen University

Status

Enrolling

Conditions

Breast Neoplasm Female

Treatments

Diagnostic Test: Collect blood and urine,pathological specimens if necessary

Study type

Observational

Funder types

Other

Identifiers

NCT06102018
SYSKY-2022-149-02

Details and patient eligibility

About

The goal of this observational study is to find the diagnostic biomarkers in serum and urine from early breast cancer patients. The main questions it aims to answer are:

  • compare the different biomarkers in serum and urine from breast cancer patients, benign lesions and healthy population.
  • construct the best diagnostic model by machine learning to distinguish breast cancer and non-breast cancer patients.

Participants, including breast and non-breast cancer patients will be asked to provides blood and urine during their diagnosis and treatment process without changing the original treatment. When necessary, specimens will be collected during the surgery,without affecting pathological diagnosis.

Enrollment

150 estimated patients

Sex

Female

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Signing the consent of informedness;
  2. Patients with breast mass who need surgery after examination;
  3. Cardiac ultrasound indicates that the blood score of the heart is within the normal range;
  4. ECOG≤0-2 points;
  5. Oversure function is acceptable.

Exclusion criteria

  1. Merge other malignant tumors such as gynecologic oncology;
  2. After evaluation, the internal organs are not suitable.

Trial design

150 participants in 3 patient groups

Breast cancer patients
Description:
No intervention. The patients who are diagnosed as breast cancer by postoperative pathological.
Treatment:
Diagnostic Test: Collect blood and urine,pathological specimens if necessary
Patients with benign breast lesions
Description:
No intervention. The patients who are diagnosed asbenign breast lesions by postoperative pathological.
Treatment:
Diagnostic Test: Collect blood and urine,pathological specimens if necessary
Healthy population
Description:
No intervention. The volunteers.
Treatment:
Diagnostic Test: Collect blood and urine,pathological specimens if necessary

Trial contacts and locations

1

Loading...

Central trial contact

Jieqiong Liu Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems